SciRhom GmbH, an advanced startup dedicated to developing transformative therapies for autoimmune diseases, today announced the appointment of their Clinical Advisory Board.
SciRhom GmbH, a developer of novel antibody therapies, announced today an increase of their seed capital by EUR 8 million. With this added investment, the company has secured a total of EUR 16 million...